Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTORERNE I GILLELEJE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   5.4% 4.6% 4.4% 3.1% 3.6% 3.3% 19.6% 19.2%   Credit score (0-100)   43 46 45 56 52 55 6 7   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,574 3,301 3,602 3,750 3,854 3,797 0.0 0.0   EBITDA   1,597 1,239 1,387 964 1,010 890 0.0 0.0   EBIT   1,558 1,180 1,258 834 881 774 0.0 0.0   Pre-tax profit (PTP)   1,558.4 1,178.0 1,229.0 827.7 872.1 774.0 0.0 0.0   Net earnings   1,213.9 915.8 957.4 640.8 677.4 599.5 0.0 0.0   Pre-tax profit without non-rec. items   1,558 1,178 1,229 828 872 774 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   283 486 1,088 959 830 714 0.0 0.0   Shareholders equity total   1,421 1,117 1,158 841 919 818 18.2 18.2   Interest-bearing liabilities   1.8 5.6 362 265 171 65.3 0.0 0.0   Balance sheet total (assets)   2,010 1,744 2,049 1,502 1,734 1,412 18.2 18.2   Net Debt   -1,526 -1,100 -387 -164 -616 -385 -18.2 -18.2     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,574 3,301 3,602 3,750 3,854 3,797 0.0 0.0   Gross profit growth   7.8% -7.7% 9.1% 4.1% 2.8% -1.5% -100.0% 0.0%   Employees   4 5 4 5 5 5 0 0   Employee growth %   0.0% 25.0% -20.0% 25.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,010 1,744 2,049 1,502 1,734 1,412 18 18   Balance sheet change%   2.9% -13.2% 17.5% -26.7% 15.5% -18.6% -98.7% 0.0%   Added value   1,596.8 1,239.0 1,386.9 963.5 1,010.3 889.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   111 144 473 -259 -259 -231 -714 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   43.6% 35.7% 34.9% 22.2% 22.9% 20.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   78.7% 62.9% 66.3% 47.0% 54.4% 49.3% 0.0% 0.0%   ROI %   111.0% 91.7% 92.5% 60.6% 75.1% 72.8% 0.0% 0.0%   ROE %   87.1% 72.2% 84.1% 64.1% 77.0% 69.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   70.7% 64.0% 56.5% 56.0% 53.0% 57.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -95.6% -88.8% -27.9% -17.0% -61.0% -43.3% 0.0% 0.0%   Gearing %   0.1% 0.5% 31.2% 31.5% 18.6% 8.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 48.5% 15.6% 2.1% 4.1% 1.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   5.3 2.8 2.1 1.1 1.3 1.6 0.0 0.0   Current Ratio   5.3 2.8 2.2 1.2 1.3 1.6 0.0 0.0   Cash and cash equivalent   1,528.1 1,105.2 749.2 428.7 786.4 450.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,360.6 776.4 491.9 66.1 185.3 255.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   399 248 347 193 202 178 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   399 248 347 193 202 178 0 0   EBIT / employee   390 236 314 167 176 155 0 0   Net earnings / employee   303 183 239 128 135 120 0 0